DiaGenomi

DiaGenomi Diagenomi Ltd. is a young high-tech company that offers services and solutions in three different ar Among other DiaGenomi Ltd.

We have made an important step towards personalized medicine with the introduction of pathology supported genetic tests like CardioRISQ, which gives individuals guidelines for a healthier lifestyle and reduction of potential cardiovascular complications. As well we provide tests that enable physicians to effectively and quickly adapt treatment decisions for individual patients with the genetic analysis of breast and colon cancer samples. is also involved in educational programs, where it offers workshops for molecular techniques such as quantitative PCR. For this reason we developed a stand alone computes program for data analysis and normalization. also collaborates with several research groups in basic research.

UKC Maribor in Diagenomi
24/10/2019

UKC Maribor in Diagenomi

Študije so dokazale, da kar 46 odstotkov bolnic s klinično visokim rizikom ponovitve raka nima koristi od kemoterapije. Genomski test raka dojke zmanjšuje uporabo kemoterapije. Žal pa morajo bolnice teste plačevati same.

Potrebujete kemoterapijo ali ne? Genomski test MammaPrint ter BluePrint lahko podata odgovor ali lahko varno opustite zd...
30/08/2017

Potrebujete kemoterapijo ali ne? Genomski test MammaPrint ter BluePrint lahko podata odgovor ali lahko varno opustite zdravljenje s kemoterapijo.
Informacije o MammaPrint testu so odslej na voljo v slovenščini na http://www.mammaprint.si/

14/05/2017
Barcelona, Camp Nou connecting with best football clubs in world
13/05/2017

Barcelona, Camp Nou connecting with best football clubs in world

22/03/2017

In the largest German survey on heart failure to date, investigators found that the overall awareness of heart failure has not increased over the past decade and is not at a satisfactory level. In 2..

No doubt, genomics-only approach to health risk assessments are known to have its limitations. DiaGenomi overcomes limit...
10/02/2017

No doubt, genomics-only approach to health risk assessments are known to have its limitations. DiaGenomi overcomes limitations and integrates genotyping in a multidisciplinary framework and includes diverse patient data (i.e., biochemistry, nutritional, lifestyle, and environmental data) to provide a wholesome health risk analysis capable of detecting areas of risks and prevention/treatment strategies beyond traditional health risk assessments.
https://www.myrisq.com/cardiorisq

and combines the analysis of various factors that influence your health. In most cases, mutations in your genome can trigger the start of disease and poor lifestyle choices can only accelerate its progress. It is therefore important to closely monitor each group of factors and determine elements tha...

02/02/2017

Lipid profiling coupled with nutrition and lifestyle analysis can offer so much more when analysis screens also for mutations in CV genes. CVD risks may be determined as much higher, unique nutritional needs may have to be addressed. Genetically assisted Health Risk Assessments will help determine beast treatment/prevention strategies.

Genetics can make traditional Health Risk Assessment (HRA) shine!Carefully selected genetic markers, when integrated wit...
25/01/2017

Genetics can make traditional Health Risk Assessment (HRA) shine!

Carefully selected genetic markers, when integrated with biometric screening, traditional HRA and lifestyle assessment can detect individual nutritional needs and future health risks.
These many times cannot be picked-up and properly addressed by only analyzing lifestyle and biometric data due to our genes interacting with other genes and the environment. These interactions may form inefficiencies in important metabolic processes involved in CV function an have great health implications that cannot be addressed only by an increase in physical activity and employment of healthy eating habits. With
help of geneticists and nutritionits best prevention or treatment approach can be chosen.
CardioRISQ assessment is such genetically assisted HRA https://www.myrisq.com/cardiorisq-for-physicians

The value of genetic Health Risk Assessment is increasingly recognized to:
- diagnose treatable subtypes of complex diseases that may include single gene disorders,
- facilitate prevention of cumulative…

Even among those at highest genetic risk, lifestyle factors can reduce incidence by one half.Healthy lifestyle  can redu...
05/12/2016

Even among those at highest genetic risk, lifestyle factors can reduce incidence by one half.

Healthy lifestyle can reduce the risk of heart disease. But what about people who have inherited gene variants known to increase risk? They can benefit from it too!

According to "ScienceDaily.com", a study led by Massachusetts General Hospital (MGH) investigators has found that, even among those at high genetic risk, following a healthy lifestyle can cut in half the probability of a heart attack or similar event. Their report is receiving early online publication in the New England Journal of Medicine to coincide with a presentation at the American Heart Association (AHA) Scientific Sessions.

It is well known that following a healthy lifestyle -- not smoking, avoiding excess weight and getting regular exercise -- can reduce the risk of heart disease. But what about people who have inherited gene variants known to increase risk? A study has found that, even among those at high genetic ris...

06/06/2016

In a recent study of 47 National Hockey League (NHL) players ACL injuries in ice hockey were identified to shorten professional careers, on ice productivity, number of games played.

These findings scream for identification of ligament injury-prone athletes by physical and genetic screening and establishing pre-habilitative protocols for such individuals.

SportInjuryRISQ (https://www.myrisq.com/sportinjuryrisq)
test screens athletes for genetic predisposition and for ligament injuries, particularly ACL and AT.


http://www.ncbi.nlm.nih.gov/pubmed/26667371

Am J Sports Med. 2016 Feb;44(2):378-83. doi: 10.1177/0363546515616802. Epub 2015 Dec 14.

02/06/2016

Continued smoking after a diagnosis of multiple sclerosis (MS) appears to be associated with accelerated disease progression compared with those patients who quit smoking, according to an article.

Address

Tehnološki Park 19
Ljubljana
1000

Telephone

+38616202584

Website

http://www.diagenomi.eu/

Alerts

Be the first to know and let us send you an email when DiaGenomi posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Practice

Send a message to DiaGenomi:

Share

Share on Facebook Share on Twitter Share on LinkedIn
Share on Pinterest Share on Reddit Share via Email
Share on WhatsApp Share on Instagram Share on Telegram